Gestational Diabetes Mellitus: A Study of Women Who Fail to Attend Appointments

Similar documents
COMPLICATIONS OF PRE-GESTATIONAL AND GESTATIONAL DIABETES IN SAUDI WOMEN: ANALYSIS FROM RIYADH MOTHER AND BABY COHORT STUDY (RAHMA)

Gestational Diabetes Mellitus (GDM) and Diabetes in Pregnancy: Diagnostic Recommendations, NSLHD

Diabetes Educator. Australian. Diabetes in Pregnancy. Policy Discussion. GDM Model of Care the Role of the Credentialled Diabetes Educator

GESTATIONAL DIABETES for GP Obstetric Shared Care Accreditation Seminar. Simon Kane March 2016

The New GDM Screening Guidelines. Jennifer Klinke MD, FRCPC Endocrinologist and Co director RCH Diabetes in Pregnancy Program

Gestational Diabetes in Rural Antenatal Clinics:

The Ever-Changing Approaches to Diabetes in Pregnancy

Screening, Diagnosis and Management of Gestational Diabetes in New Zealand: A Clinical Practice Guideline

Gestational Diabetes: An Update on Testing. Kimberlee A McKay, M.D. Avera Medical Group Ob/GYN

Gestational Diabetes Mellitus Dr. Fawaz Amin Saad

Effect of Various Degrees of Maternal Hyperglycemia on Fetal Outcome

DIABETES WITH PREGNANCY

Vishwanath Pattan Endocrinology Wyoming Medical Center

Continuous Glucose Monitoring in Women With Type 1 Diabetes in Pregnancy Trial

Management of Pregestational and Gestational Diabetes Mellitus

Screening and Diagnosis of Diabetes Mellitus in Taiwan

Research Article Implementation of the International Association of Diabetes and Pregnancy Study Groups Criteria: Not Always a Cause for Concern

2/13/2018. Update on Gestational Diabetes. Disclosure. Objectives. I have no financial conflicts of interest.

Epidemiology and Prevention

GESTATIONAL DIABETES MELLITUS AND SUBSEQUENT MANAGEMENT OF CONFIRMED GESTATIONAL DIABETES MELLITUS (GDM) AND SELECTIVE SCREENING - CLINICAL GUIDELINE

Wellness Coaching for People with Prediabetes

Type 1 diabetes accounts for 5e10% of diabetes diagnoses,

Pregnancy and Diabetes

Reminder: NPIC/QAS CME/CEU Program

Diagnosis of gestational diabetes mellitus: comparison between National Diabetes Data Group and Carpenter Coustan criteria

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

GESTATIONAL DIABETES TESTING AND TREAMENT

Diabetes in Pregnancy Network: Scoping survey March 2013

Gestational Diabetes. Benjamin Byers, D.O., FACOG Center for Maternal and Fetal Care Bryan Physician Network

Diabetes and Pregnancy

A novel validated model for the prediction of insulin therapy initiation and adverse perinatal outcomes in women with gestational diabetes mellitus

Postpartum Diabetes Screening: adherence rate and the performance of fasting plasma glucose versus oral glucose tolerance test

Cadmium body burden and gestational diabetes mellitus in American women. Megan E. Romano, MPH, PhD

Original paper A.-S. MARYNS 1, I. DEHAENE 1, G. PAGE 2. Abstract

National Pregnancy in Diabetes Audit Report, England, Wales and the Isle of Man 12th October 2017

Maternal Child Health and Chronic Disease

Early life influences on adult chronic

Gestational Diabetes. Gestational Diabetes:

Surveillance report Published: 9 January 2017 nice.org.uk

Effect of Gestational Diabetes mellitus Health Education Module on Pregnancy Outcomes

Diabetes in pregnancy

Socioeconomic inequalities in lipid and glucose metabolism in early childhood

A CLINICAL STUDY OF GESTATIONAL DIABETES MELLITUS IN A TEACHING HOSPITAL IN KERALA Baiju Sam Jacob 1, Girija Devi K 2, V.

MANAGEMENT OF DIABETES IN PREGNANCY

To see a description of the Academy Recommendation Rating Scheme (Strong, Fair, Weak, Consensus, Insufficient Evidence), click here.

Cynthia Feltner, MD MPH

Pregnancy outcomes in Korean women with diabetes

The Role of the Diabetes Educator within the Patient-Centered Medical Home & Future Roles

Diabetes in pregnancy

Dr Shelley Wilkinson AdvAPD NHMRC TRIP Fellow/Senior Research Dietitian Maternal Health Mater Health Services/Mater Medical Research Institute

RETIRED: REVIEWED/Revised: 12/14; 10/15; 1/16; 9/16, 10/16, 5/17, 5/18, 9/18

Management of Gestational Diabetes

Ott et al. BMC Pregnancy and Childbirth (2018) 18:250 (Continued on next page)

A S Y N T H E S I Z E D H A N D B O O K ON G E S T A T I O N A L D I A B E T E S

Diabetes in Pregnancy

Pregnancy Smoking Intervention in NE Tennessee: Effectiveness Data from the First Two Years of TIPS

Optimizing Postpartum Maternal Health to Prevent Chronic Diseases

The Aboriginal Maternal and Infant Health Service: a decade of achievement in the health of women and babies in NSW

Diabetes in pregnancy

Tuberculosis and Diabetes

Nevada Journal of Public Health, (2010). Vol. 7 Shen et al., 27

Hepatitis B vaccine alone or with HBIG in neonates of HBsAg+/HBeAg- mothers: a systematic review and meta-analysis.

2018 Standard of Medical Care Diabetes and Pregnancy

Gestational Diabetes: Long Term Metabolic Consequences. Outline 5/27/2014

Screening, Diagnosis and Management of Gestational Diabetes in New Zealand. A clinical practice guideline

Comparative Study between Acarbose and Insulin in the Treatment of GDM.

ADVERSE PREGNANCY OUTCOMES IN GESTATIONAL DIABETES MELLITUS - STUDY IN AN APEX HOSPITAL

Oral glucose lowering agents in gestational diabetes. Yes: E. Sobngwi (Cameroon) No: A. Vambergue (France)

CommUnityCare Women s Health Brackenridge Professional Office Building

Gestational diabetes

Gestational Diabetes in Resouce. Prof Satyan Rajbhandari (RAJ)

HbA1c level in last trimester pregnancy in predicting macrosomia and hypoglycemia in neonate

Aneurin Bevan University Health Board Diabetes in Pregnancy: Care Pathway for Management of Diabetes in Pregnancy

METFORMIN A CONVENIENT ALTERNATIVE TO INSULIN FOR INDIAN WOMEN WITH DIABETES IN PREGNANCY

Obstetrics and Gynaecology

Low uptake of postpartum screening for Type 2 diabetes in women after a

Surveillance report Published: 8 June 2017 nice.org.uk. NICE All rights reserved.

Diabetes in obstetric patients

GDM. Literature Review. GESTATIONAL DIABETES MELLITUS: A review for midwives AUTHORS BACKGROUND CONTRIBUTORS TABLE OF CONTENTS

Risk factors of gestational diabetes mellitus among the re-birth pregnant women in Xiamen City in

Current Trends in Diagnosis and Management of Gestational Diabetes

Trends in Obstetric and Perinatal Outcomes of Women with Type 1 Diabetes During

Overview. In Vitro Fertilization: a Success Story

Diabetes in Pregnancy. L.Sekhavat MD

Diabetes Mellitus: Management of Gestational Diabetes

Maternal and Fetal Outcomes if Gestational Impaired Glucose Tolerance Is Not Treated

Improving Health Services for Diabetic Pregnant Women who are Attending Governmental Clinics in Nablus and Jenin Districts.

Diet Quality and History of Gestational Diabetes

Danielle M Nash, Dr. Jason A Gilliland, Dr. Susan E Evers, Dr. Piotr Wilk & Dr. M Karen Campbell. JNEB Journal Club November 3, 2014

Dr Aftab Ahmad Consultant Diabetologist at Royal Liverpool University Hospital Regional Diabetes Network Lead

Trust Guidelines for the Diagnosis and Management of Gestational Diabetes Mellitus (GDM)

METABOLIC SYNDROME IN REPRODUCTIVE FEMALES

2204 Diabetes Care Volume 39, December 2016

Laura Smith University of Cincinnati. June 7 th, 2012

An Adaptive Reinforcement-Based Treatment (RBT) Intervention for Pregnant Substance Dependent Women

DIABETES MELLITUS IN PREGNANCY; MATERNAL & PRENATAL OUTCOME

It s Never Too Early To Prevent Diabetes: The Lasting Impact of Gestational Diabetes on Mothers and Children

Diabetes in pregnancy among Sri Lankan women: gestational or pre-gestational?

EVALUATION OF THYROID FUNCTION IN PRE-ECLAMPSIA

Isolated proteinuria in Chinese pregnant women with pre-eclampsia: Results of retrospective observational study

Transcription:

Gestational Diabetes Mellitus: A Study of Women Who Fail to Attend Appointments Vincent W. Wong, MBBS, FRACP, PhD, Shanley Chong, PhD, Cecilia Astorga, BSc, and Bin Jalaludin, MBBS, MRCP, FAFPHM, PhD One of the challenges clinicians face in managing patients with diabetes is to ensure that patients comply with their therapy. Patients may lack motivation to adhere to recommendations from diabetologists, diabetes nurse educators, and dietitians, and their attendance to clinic appointments can be erratic. A recent study demonstrated that clinic nonattendance and noncompliance to therapy were both independent predictors of mortality for patients with type 2 diabetes. 1 Women with gestational diabetes mellitus (GDM) are usually informed by their obstetrics or diabetes team (at their first educational session) that suboptimal glycemic control could affect the well-being of their developing fetuses, and this may provide greater motivation for them to adhere to therapy. In addition to antenatal visits, women with GDM must attend education sessions on GDM management, and they require regular follow-up with their diabetes team until delivery. To date, there is little information in the literature addressing compliance issues for women with GDM. Because optimal GDM management has been shown to affect pregnancy outcomes for women with GDM, we hypothesized that nonattendance to diabetes-related appointments may have adverse effects on the pregnancy outcomes of women with GDM. In this study, we assessed the attendance of diabetes-related appointments for women with GDM and explored clinical factors that were associated with failureto-attend (FTA) rates for these women in a single public hospital in the southwestern part of Sydney, Australia. We also evaluated the pregnancy outcomes of women with GDM who had failed to attend two or more of their diabetes appointments during pregnancy. Materials and Methods A retrospective review was conducted on all pregnant women who were diagnosed with GDM and who had received diabetes education at the Diabetes Centre at Liverpool Hospital between 1 January and 31 December 2011. Demographic data, including age, parity, BMI, ethnicity, family history of diabetes, history of previous GDM, glucose tolerance test results, A1C, and need for insulin therapy, were documented. The women s scores on the Edinburgh Depression Scale (EDS) at the first antenatal visit were also noted. Pregnancy outcomes including prematurity (< 37 weeks), birth weight, birth weight percentile, Apgar scores, fetal death, and admission to the neonatal intensive care unit (NICU) were recorded. Macrosomia was defined by a birth weight of > 90th percentile. Attendance at diabetes-related services during pregnancy was recorded in the hospital appointment system. Women who failed to attend appointments with two clinicians scheduled on the same day were counted as having missed one appointment. Women who failed to attend two or more diabetesrelated clinic appointments were identified as multi-fta. The well-attended group was composed of women who attended all scheduled appointments or missed no more than one appointment throughout their pregnancy. 267

At Liverpool Hospital, a tertiary referral center located in the southwestern part of Sydney, Australia, women diagnosed with GDM were booked into a diabetes group seminar conducted by a diabetes nurse educator (DNE) and dietitian at the Diabetes Centre. During the 2-hour session, these women were educated about blood glucose monitoring and given advice on medical nutritional therapy. The DNE also discussed the implications of GDM on the developing fetus and informed the women about their future risk of developing type 2 diabetes. These women were followed up at the high-risk antenatal clinic, a multidisciplinary clinic staffed by midwives, obstetricians, renal physicians, endocrinologists, DNEs, and a dietitian. Most of the subsequent appointments were coordinated such that the women would see the obstetrics and diabetes teams at the same clinic on the same day. The frequency of diabetes-related appointments was dependent on the women s glycemic profile and dietary-related issues. Women who required insulin therapy would attend an extra education session at the Diabetes Centre to learn how to self-inject. Interpreters were readily available when required. Statistical Analysis Continuous variables were expressed as median and interquartile range, whereas categorical variables were expressed as percentages. A nonparametric method was used to compare all continuous variables between binary outcomes. χ 2 Testing was used to compare categorical variables between binary outcomes. Differences were considered significant at the level of P < 0.05. All variables were first tested in a univariate model. Only variables with a P < 0.25 were included in the multivariate model. To assess the associations between binary outcome variable and potential clinical factors, a logistic regression model was used. For predicting multi-fta, these variables were ethnicity, parity, previous GDM, requirement for insulin therapy, BMI, and A1C at diagnosis. For predicting macrosomia, these variables were ethnicity, parity, need for insulin therapy, BMI, and multi-fta. The study was approved by the Sydney South West Area Health Table 1. Characteristics of Women with GDM Who Missed Two or More Appointments (Multi-FTA) Compared to Women Who Fully Attended or Missed Only One Appointment (Compliant) Compliant (n = 286) 268 Multi-FTA (n = 80) Test Statistics Median age (years [range]) 31 (17 46) 31 (17 43) Kruskal-Wallis, P = 0.73 Parity = 0 (n [%]) 106 (37.2) 19 (24.0) χ 2 = 4.74, P = 0.03 χ 2 = 6.38, P = 0.04 BMI Normal (< 25 kg/m 2 ) (n [%]) Overweight (25 30 kg/m 2 ) (n [%]) Obese (> 30 kg/m 2 ) (n [%]) 125 (44.1) 84 (29.7) 74 (26.1) 30 (38.0) 17 (21.5) 32 (40.5) Family history of diabetes (n [%]) 143 (50.0) 41 (51.3) χ 2 = 0.04, P = 0.84 Previous GDM (n [%]) 51 (17.8) 27 (33.8) χ 2 = 9.45, P < 0.01 Weeks of gestation when GDM diagnosed (median [range]) Ethnicity Southeast Asians (n [%]) South Asians (n [%]) Middle Easterners (n [%]) Anglo-Europeans (n [%]) Others (n [%]) 27 (18 35) 25 (16 32) Kruskal-Wallis, P = 0.08 χ 2 = 19.6, P < 0.01 66 (23.1) 60 (21.0) 60 (21.0) 71 (24.8) 29 (10.1) 14 (17.5) 15 (18.8) 26 (32.5) 7 (8.8) 18 (22.5) Requiring interpreter service (n [%]) 61 (21.3) 19 (23.8) χ 2 = 0.21, P = 0.64 Smokers (n [%]) 11 (3.8) 5 (6.3) χ 2 = 0.86, P = 0.35 Results of 75-g glucose tolerance test Fasting glucose level (mmol/l [range]) Fasting glucose level (mg/dl [range]) 2-hour glucose level (mmol/l [range]) 2-hour glucose level (mg/dl [range]) 5.1 (3.5 5.9) 82 (63 106) 8.4 (4.0 18.0) 151 (72 324) 5.5 (3.7 12.5) 99 (67 225) 8.2 (4.3 13.0) 148 (77 234) Kruskal-Wallis, P < 0.01 Kruskal-Wallis, P = 0.11 A1C at diagnosis 5.5% (37 mmol/mol) (n [%]) 126 (45.0) 40 (53.3) χ 2 = 1.65, P = 0.20 Number of diabetes appointments (medial [range]) 8 (1 18) 8 (0 25) Kruskal-Wallis, P = 0.79

Service Human Research Ethics Committee. Results Between January and December 2011, 366 women with GDM received diabetes education at the Liverpool Hospital Diabetes Service. The women had a median of eight diabetes-related clinic appointments during pregnancy. Among these women, 37.2% (136 women) missed at least one appointment during their pregnancy, whereas 21.9% (80 women) missed appointments at least twice (multi-fta group). Twentytwo women missed at least four of their diabetes-related appointments. Women in the multi-fta group had greater BMIs, were less likely to be nulliparous, had a significantly higher rate of previous GDM, and were likely to be from a non- European background (Table 1). There were no differences between the multi-fta and well-attended groups in the need for interpreters, scores on the EDS, or total number of diabetes-related appointments during pregnancy. In terms of their metabolic profiles, women in the multi-fta group had higher fasting glucose levels on their glucose tolerance test at the time of GDM diagnosis. On multivariate logistic regression analysis, previous GDM and certain non-anglo-european ethnicities (South Asians, Middle Easterners, and others) were independent predictors for multi-fta (Table 2). At 36 weeks gestation, 272 women had a repeat A1C measurement. Those in the multi-fta group had poorer glycemic control, as indicated by a greater proportion of women in this group having an A1C > 5.5% (Table 3). More of them required insulin therapy. In terms of pregnancy outcomes, women in the multi-fta group gave birth to neonates with significantly larger birth weight and higher birth weight percentile, and a greater proportion were macrosomic (Table 3). There was a trend toward higher rates of neonate admission into the NICU in the multi-fta group, but mode of delivery, proportion of premature births, neonates with low Apgar scores, and peri-natal deaths were not significantly different compared to those in the compliant group. Using multivariate logistic regression analysis taking into account factors such as maternal BMI, parity, ethnicity, and insulin use, women in the multi-fta group had an increased risk of macrosomia (odds ratio [OR] 1.98, 95% CI 0.93 4.18, P = 0.076). Discussion The reasons behind nonattendance of antenatal services were complex Table 2. Multivariate Logistic Regression Analysis of Factors Predicting Multi-FTA Predictor OR 95% CI P Ethnicity Anglo-Europeans Southeast Asians South Asians Middle Easterners Others 1.0 2.4 3.0 5.4 7.9 0.8 7.4 1.1 8.7 2.0 14.7 2.7 23.0 0.12 0.04 < 0.01 < 0.01 Parity = 0 yes versus no 0.9 0.4 1.7 0.71 Previous GDM yes versus no 2.4 1.2 4.7 0.01 BMI < 25 kg/m 2 25 30 kg/m 2 > 30 kg/m 2 1.0 1.1 0.7 0.5 2.5 0.3 1.5 0.77 0.39 A1C at diagnosis 5.5% (37 mmol/mol) yes versus no 1.1 0.6 1.9 0.88 and involved factors relating to women s perceived value of the services, clinic set-up, and women s level of understanding of their condition and how it affects fetal well-being. 2,3 Campbell et al. 4 reported a no-show rate of 28% at their high-risk obstetric clinic. A number of studies have identified several sociodemographic factors related to late initiation or inadequate adherence to antenatal care. These have included high parity, low income, and membership in a minority ethnic group. 2,3,5 7 In the literature, there has not been any study specifically assessing the clinic attendance of women with GDM. Because unforeseen circumstances could preclude women from attending one of the many appointments scheduled during pregnancy, we chose women who missed at least two appointments as our reference FTA group (multi-fta). In our cohort, a substantial number of women with GDM (more than onefifth) missed their diabetes-related appointments two or more times during their pregnancy. We demonstrated that women with GDM who frequently missed their appointments were more likely to have previous GDM and were often from non-european ethnic groups. Women with children (parity > 0) were more likely to miss appointments, but this association was no longer significant in multivariate analysis. We also showed that depression scores on EDS did not differ between those who attended the program fully and those in the multi-fta group. We observed that women with previous GDM had a greater risk of multi-fta. These women could be more confident with GDM management from their previous experience, but it was not clear if that led to a lower threshold for missing appointments. For women with previous GDM and stable diabetes control, one might argue that these women could be reviewed at the clinic less frequently, and phone consultations could be employed more readily in these women. Although women from a non- Anglo/European background had a higher multi-fta rate, this was 269

Table 3. Pregnancy Outcomes of Multi-FTA Women Compared to Compliant Women Compliant Multi-FTA Test Statistics (n = 286) (n = 80) A1C at 36 weeks 5.5% (37 mmol/mol) (n [%])* 95 (42.9) 31 (60.8) χ 2 = 2.3, P = 0.02 Need insulin therapy (n [%]) 114 (39.9) 42 (52.5) χ 2 = 4.08, P = 0.04 Gestational week of delivery (medial [range]) 39 (33 41) 39 (30 41) Kruskal-Wallis, P = 0.26 Prematurity (delivery at < 37 weeks) (n [%]) 7 (2.4) 4 (5.0) χ 2 = 1.3, P = 0.25 χ 2 = 4.9, P = 0.18 Method of delivery Emergency Caesarian section (n [%]) Elective Caesarian section (n [%]) Induction of labor (n [%]) Spontaneous vaginal delivery (n [%]) not related to the need for interpreters. Apart from language barriers, cultural differences and level of health literacy in these women could possibly affect the likelihood for nonattendance to appointments. These women would need more time and greater resources to help them understand their condition better and adhere to recommendations. The others ethnic group consisted of women from the Pacific Islands, Africa, and South America, and they had a significantly high nonattendance rate. However, because of the small number of women in each of these groups, separate analysis for each group was not valid. The important question was whether attendance at diabetesrelated appointments mattered in terms of pregnancy outcomes. In our study, those in the multi-fta group had poorer glycemic control by 36 weeks, and their risk of macrosomia was higher. There was no difference in other pregnancy outcomes, although there was a trend toward increased risk of admission to the NICU. One other study, 6 which was not limited to women with GDM, demonstrated that poor attendance at antenatal clinic appointments 16 (5.6) 56 (19.6) 62 (21.7) 143 (50.0) was associated with lower 5-minute Apgar scores of neonates, higher risk for fetal and neonatal death, and higher risk of placental abruption and intrauterine infections. At our institution, women with GDM attended a mean of eight diabetes-related appointments throughout their pregnancy. Although most of the diabetesrelated appointments were made in conjunction with obstetrics visits, attending all of the appointments could still be challenging, especially for women who worked or had young children at home. Our analysis showed no association between the number of diabetes-related appointments and the FTA rate. Nevertheless, it would be difficult to assess the impact to a woman s GDM management if she missed two out of a total of four appointments compared to missing two out of 10 appointments. The most common reasons women gave for nonattendance included lack of transportation, unsuitable appointment times, need to care for a sick child or relative, and lack of available child care facilities. 2,4 Apart from reinforcing the importance of good diabetes control 270 9 (11.3) 10 (12.5) 19 (23.8) 38 (47.5) Perinatal deaths (n [%]) 1 (0.3) 1 (1.3) χ 2 = 0.9, P = 0.33 Birth weight (kg [range]) 3.3 (1.9 4.9) 3.5 (1.6 5.6) Kruskal-Wallis, P = 0.01 Macrosomia (birth weight 90th percentile) (n [%]) 30 (10.5) 18 (22.5) χ 2 = 7.6, P = 0.01 Apgar score at 5 minutes 7 (n [%]) 5 (1.7) 3 (3.8) χ 2 = 1.1, P = 0.29 Need for NICU admission (n [%]) 7 (2.4) 5 (6.3) χ 2 = 2.9, P = 0.09 *A total of 272 women had repeat A1C testing at 36 weeks of gestation, including 221 in the compliant group and 51 in the multi-fta group. on pregnancy outcomes, improving the clinic set-up for these women could be vital. Strategies such as offering more flexible appointment times, maintaining shorter waiting times at the clinic, and providing a more child-friendly environment at the clinic could improve clinic attendance, but these strategies would demand greater health resources. To reduce the total number of clinic appointments, phone consultations could be employed more frequently in women with stable diabetes control and those with previous GDM. However, face-to-face reviews were still invaluable in that they provided more comprehensive assessment of women s diabetes control and nutritional status. A study using a telemedicine system 8 was highly effective in enhancing communication between women with GDM and clinicians, but pregnancy outcomes were not different. There were a few limitations in our study. Information such as the education level and socioeconomic status of the women, which could affect the FTA rate, was not available. The findings of this study also could not be extrapolated to other models of care (e.g., clinics in the pri-

vate sector) where the service set-up, such as the scheduling of appointments and waiting times, is different. The socioeconomic background, level of health literacy, and perception of health care could also differ between women who choose private versus public antenatal services. Finally, other facets of compliance to GDM management, including adherence to self-monitoring of blood glucose, medical nutrition therapy, and insulin therapy, were not assessed in this study. In summary, this was the first study assessing factors associated with multi-fta of GDM appointments at a public hospital. At our institution, we found that women with previous GDM and those belonging to certain ethnic groups had higher rates of multi-fta. Because effective diabetes management affects both maternal and fetal well-being, each institution should review its FTA rates and formulate strategies to improve attendance of these women. References 1 Currie CJ, Peyrot M, Morgan CL, Poole CD, Jenkins-Jones S, Rubin RR, Burton CM, Evans M: The impact of treatment noncompliance on mortality in people with type 2 diabetes. Diabetes Care 35:1279 1284, 2012 2 Blankson ML, Goldenberg RL, Keith B: Noncompliance of high-risk pregnant women in keeping appointments at an obstetric complications clinic. South Med J 87:634 638, 1994 3 Sword W: Prenatal care use among women of low income: a matter of taking care of self. Qual Health Res 13:319 332, 2003 4 Campbell JD, Chez RA, Queen T, Barcelo A, Patron E: The no-show rate in a high-risk obstetric clinic. J Womens Health Gend Based Med 9:891 895, 2000 5 Beeckman K, Louckx F, Putman K: Determinants of the number of antenatal visits in a metropolitan region. BMC Public Health 10:527, 2010 6 Raatikainen K, Heiskanen N, Heinonen S: Under-attending free antenatal care is associated with adverse pregnancy outcomes. BMC Public Health 7:268, 2007 7 Petrou S, Kupek E, Vause S, Maresh M: Clinical, provider and sociodemographic determinants of the number of antenatal visits in England and Wales. Soc Sci Med 52:1123 1134, 2001 8 Homko CJ, Deeb LC, Rohrbacher K, Mulla W, Mastrogiannis D, Gaughan J, Santamore WP, Bove AA: Impact of a telemedicine system with automated reminders on outcomes in women with gestational diabetes mellitus. Diabetes Technol Ther 14:624 629, 2012 Vincent W. Wong, MBBS, FRACP, PhD, is director of the Diabetes and Endocrine Service at Liverpool Hospital and a conjoint associate professor at the University of New South Wales in Sydney, Australia. Shanley Chong, PhD, is biostatistician at the Centre for Research, Evidence Management and Surveillance in Liverpool, Sydney, Australia. Cecilia Astorga, BSc, is a clinical nurse consultant at the Diabetes and Endocrine Service at Liverpool Hospital. Bin Jalaludin, MRCP, FAFPHM, PhD, is a conjoint professor at the University of New South Wales and director of the Centre for Research, Evidence Management and Surveillance. 271